Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-02 Sale | 2025-01-03 5:05 pm | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 10,826 | $0.5619 | $6,083 | 129,174 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:04 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 25,107 | $0.5619 | $14,108 | 478,947 (Indirect Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:03 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 8,510 | $0.5619 | $4,782 | 204,094 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:01 pm | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 2,881 | $0.5619 | $1,619 | 114,442 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:00 pm | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 8,510 | $0.5619 | $4,782 | 157,068 (Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:51 pm | Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer | 1,272 | $0.566 | $720 | 97,532 (Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:50 pm | Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO | 2,525 | $0.566 | $1,429 | 20,870 (Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:49 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 2,525 | $0.566 | $1,429 | 92,684 (Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:48 pm | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 2,525 | $0.566 | $1,429 | 51,927 (Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:47 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 5,032 | $0.566 | $2,848 | 179,054 (Indirect Direct) | View |
| 2024-06-21 Purchase | 2024-06-25 7:21 pm | Athira Pharma Inc. | ATHA | Romano Kelly A Director | 42,400 | $2.3597 | $100,051 | 80,715 (Direct) | View |
| 2024-01-05 Sale(A) | 2024-02-16 4:40 pm | Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO | 2,412 | $2.91 | $7,019 | 13,395 (Direct) | View |
| 2024-01-05 Sale(A) | 2024-02-16 4:38 pm | Athira Pharma Inc. | ATHA | Litton Mark James CEO | 4,820 | $2.91 | $14,026 | 164,086 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-03 Option Award(A) | 2025-03-12 5:20 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 73,350 | $0 | 73,350 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:31 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 170,850 | $0 | 170,850 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:30 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 146,408 | $0 | 146,408 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:29 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 556,358 | $0 | 556,358 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:29 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 185,450 | $0 | 185,450 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:28 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 143,158 | $0 | 143,158 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:05 pm | N/A N/A | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 46,667 | $0 | 129,174 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:04 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 108,333 | $0 | 478,947 (Direct) | View |
| 2024-11-18 Option Award | 2025-01-03 5:03 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 9,920 | $0.55 | 204,094 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:03 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 36,667 | $0 | 204,094 (Direct) | View |
| 2024-11-18 Option Award | 2025-01-03 5:01 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 3,651 | $0.55 | 114,442 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:01 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 12,359 | $0 | 114,442 (Direct) | View |
| 2024-11-18 Option Award | 2025-01-03 5:00 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 3,651 | $0.55 | 157,068 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:00 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 36,667 | $0 | 157,068 (Direct) | View |
| 2024-10-03 Option Award(A) | 2024-10-03 9:50 pm | N/A 2034-10-02 | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 325,000 | $0 | 325,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:17 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 74,154 | $0 | 74,154 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:13 pm | N/A N/A | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 280,000 | $0 | 280,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:10 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:08 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-03 7:07 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 650,000 | $0 | 650,000 (Direct) | View |
Ownership | 2024-10-03 7:05 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 0 | $0 | 291,099 (Direct) | View |
| 2024-05-20 Option Award | 2024-09-05 7:51 pm | N/A N/A | Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer | 10,000 | $1.34 | 97,532 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:51 pm | N/A N/A | Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer | 5,000 | $0 | 97,532 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO | 10,000 | $0 | 20,870 (Direct) | View |
| 2024-05-20 Option Award | 2024-09-05 7:49 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 4,953 | $1.34 | 92,684 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:49 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 10,000 | $0 | 92,684 (Direct) | View |
| 2024-05-20 Option Award | 2024-09-05 7:48 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 10,000 | $1.34 | 51,927 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:48 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 10,000 | $0 | 51,927 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:47 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 20,000 | $0 | 179,054 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 7:03 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | Romano Kelly A Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 7:01 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 7:00 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 6:58 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | Kosacz Barbara Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 6:56 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | Panzara Michael A. Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 6:55 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | PICKERING GRANT Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 6:54 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-04-15 Option Award | 2024-04-16 4:37 pm | N/A 2034-04-14 | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 400,000 | $0 | 400,000 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 5:05 pm | N/A 2034-02-14 | Athira Pharma Inc. | ATHA | Litton Mark James CEO | 650,000 | $0 | 650,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 5:01 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:54 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:48 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER | 280,000 | $0 | 280,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:46 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:40 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO | 10,000 | $0 | 13,395 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:38 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James CEO | 20,000 | $0 | 164,086 (Direct) | View |